Evaluation of quantitative imaging parameters in head and neck squamous cell carcinoma
Tejpal Gupta(Tata Memorial Hospital), Jai P. AGARWAL(Tata Memorial Hospital), Sarbani Ghosh Laskar(Tata Memorial Hospital), Abhishek Chatterjee(Homi Bhabha National Institute), Nilendu Purandare(Tata Memorial Hospital), Ashwini Budrukkar(Tata Memorial Hospital), Supreeta Arya(Tata Memorial Hospital), Vedang Murthy(Homi Bhabha National Institute), Venkatesh Rangarajan(Tata Memorial Hospital)
The Quarterly Journal of Nuclear Medicine and Molecular Imaging
January 20, 2022
Cited by 6
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340